These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 8623202)
1. In support of the findings of Christopher F. Bryan et al. Fuller TC; Fuller A; McCormack JM; Rodey GE Transplantation; 1996 Apr; 61(7):1127-9. PubMed ID: 8623202 [No Abstract] [Full Text] [Related]
2. Pretransplant and posttransplant monitoring of anti-HLA class I IgG1 antibodies by ELISA identifies patients at high risk of graft loss. Monteiro F; Mineiro C; Rodrigues H; de Paula FJ; Kalil J Transplant Proc; 1997; 29(1-2):1433-4. PubMed ID: 9123368 [No Abstract] [Full Text] [Related]
3. Lung transplantation under a tacrolimus/mycophenolate mofetil-based immunosuppressive regimen results in low titers of HLA and MICA IgG antibodies which are not related to development of BOS. Paantjens AW; van de Graaf EA; van Ginkel WG; van den Bosch JM; Otten HG J Heart Lung Transplant; 2010 May; 29(5):596-8. PubMed ID: 20207170 [No Abstract] [Full Text] [Related]
4. Monitoring of anti-HLA and anti-Major histocompatibility complex class I related chain A antibodies in living related renal donor transplantation. Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK Transplant Proc; 2007 Apr; 39(3):759-60. PubMed ID: 17445592 [TBL] [Abstract][Full Text] [Related]
6. Management of alloimmunized, refractory patients in need of platelet transfusions. Engelfriet CP; Reesink HW; Aster RH; Brand A; Tomson B; Claas FH; Contreras M; Navarrete C; Jørgensen J; Murphy MF; Curtis R; Waters AH; Panzer S; Kurz M; Höcker P; Mayr WR; Schiffer CA Vox Sang; 1997; 73(3):191-8. PubMed ID: 9358625 [No Abstract] [Full Text] [Related]
7. [Comparative evaluation of ELISA and Luminex panel reactive antibody assays for HLA alloantibody screening]. Jung S; Oh EJ; Yang CW; Ahn WS; Kim Y; Park YJ; Han K Korean J Lab Med; 2009 Oct; 29(5):473-80. PubMed ID: 19893358 [TBL] [Abstract][Full Text] [Related]
8. Detection of HLA and MICA antibodies before kidney graft failure. Mizutani K; Shibata L; Ozawa M; Esquenazi V; Rosen A; Miller J; Terasaki PI Clin Transpl; 2006; ():255-64. PubMed ID: 18365383 [TBL] [Abstract][Full Text] [Related]
9. Use of intravenous immunoglobulin in sensitized LVAD recipients. Dowling RD; Jones JW; Carroll MS; Gray LA Transplant Proc; 1998 Jun; 30(4):1110-1. PubMed ID: 9636450 [No Abstract] [Full Text] [Related]
10. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques. Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458 [TBL] [Abstract][Full Text] [Related]
11. Relevance of posttransplant HLA class I and class II antibodies on renal graft outcome. Piazza A; Poggi E; Borrelli L; Valeri M; Buonomo O; Servetti S; Adorno D; Casciani CU Transplant Proc; 2001; 33(1-2):478-80. PubMed ID: 11266917 [No Abstract] [Full Text] [Related]
12. Evaluation of HLA-class I alloantibodies using PRA-STAT and complement-dependent cytotoxicity techniques. Papassavas AC; Iniotaki-Theodoraki A; Stathakopoulou A; Ioannou S; Kostakis A; Stavropoulos-Giokas C Transplant Proc; 1998 May; 30(3):724-6. PubMed ID: 9595073 [No Abstract] [Full Text] [Related]
13. Detection of donor-specific anti-HLA class I and II antibodies using antibody monitoring system. Yang CW; Oh EJ; Lee SB; Moon IS; Kim DG; Choi BS; Park SC; Choi YJ; Park YJ; Han K Transplant Proc; 2006 Nov; 38(9):2803-6. PubMed ID: 17112834 [TBL] [Abstract][Full Text] [Related]
14. Alloantigen-blocking antibodies in sera from highly sensitized uremic patients: antibody class and relationship with lymphocytotoxins. Shoker AS; Okasha K; Sheridan DP; Kappel JE; Baltzan MA Transplantation; 1997 Sep; 64(6):853-60. PubMed ID: 9326410 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and specificity of immunoglobulin G and immunoglobulin A non-complement-binding anti-HLA alloantibodies in retransplant candidates. Arnold ML; Dechant M; Doxiadis II; Spriewald BM Tissue Antigens; 2008 Jul; 72(1):60-6. PubMed ID: 18588575 [TBL] [Abstract][Full Text] [Related]
17. Assessing human alloimmunization as a strategy for inducing HIV type 1 neutralizing anti-HLA responses. Leith JG; Clark DA; Matthews TJ; Rosenthal KL; Luscher MA; Barber BH; MacDonald KS AIDS Res Hum Retroviruses; 2003 Nov; 19(11):957-65. PubMed ID: 14678602 [TBL] [Abstract][Full Text] [Related]